申请人:Board of Regents, The University of Texas System
公开号:US11325898B2
公开(公告)日:2022-05-10
Small molecule disruptors of Beclin-1/Bcl-2 protein-protein interactions induce autophagy and hence are useful for treating a variety of indications where stimulation of autophagy is therapeutically useful, including cancer, infection immunity, neurodegeneration, longevity.
Beclin-1/Bcl-2蛋白-蛋白相互作用的小分子干扰素可诱导自噬,因此可用于治疗各种刺激自噬的适应症,包括癌症、感染免疫、神经变性和长寿。